Plaque composition, immune activation explain cardiovascular risk in HIV-infected women

A Massachusetts General Hospital (MGH) research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In the Dec. 1 issue of the Journal of Infectious Diseases the investigators report finding that HIV-infected women had a greater prevalence of the type of coronary artery plaque most vulnerable to rupture than did uninfected women. They also found evidence that increased immune system activation may contribute to development of vulnerable plaques, an association that appears to be further amplified in older women.

"Studies have found rates of heart attack and stroke in HIV-infected patients that are from 50 to 100 percent higher than those of uninfected individuals, with particularly high rates – almost tripled in some studies – in women," says Steven Grinspoon, MD, director of the MGH Program in Nutritional Metabolism and a member of the Neuroendocrine Unit, the study's principal investigator. "Traditional cardiovascular risk factors only account for part of the excess risk, and previous studies from our group have found both increased and high-risk vulnerable plaque in HIV-infected men, but this is the first to assess these factors in HIV-infected women."

The study enrolled 90 participants – 60 HIV-infected women and 30 noninfected controls – from HIV clinics and community health centers in the Boston area. Participants were ages 18 to 60, with no known cardiovascular disease. The infected participants had long-term diagnoses, averaging 15 years; 98 percent were taking antiretroviral therapy, and 84 percent had undetectable viral loads. The researchers took detailed personal and family medical histories of the participants, ran a full range of blood tests – including assessment of immune system factors – and conducted CT angiography to assess the presence and composition of any plaques in participants' coronary arteries.

Although the overall prevalence of coronary plaques was similar between both groups, more of the HIV-infected participants had noncalcified plaques – unstable deposits of lipids and immune cells more likely to rupture – while uninfected women tended to have more stable, calcified plaques. Among infected women, 74 percent of the plaque segments in coronary arteries were noncalcified, compared with 24 percent in uninfected women. A previous study in men found noncalcified plaque in 52 percent of plaque-containing segments in those who were HIV-infected and in 41 percent of segments in uninfected men.

Among infected women, blood tests revealed elevated activity of both monocytes and T cells – reflected by higher blood levels of proteins known to be activation markers of those immune cells – and the increased activity was even greater in . An earlier study from the MGH-based Ragon Institute had found that patterns of immune activation differed between HIV-infected women and men, and the current study is the first to associate monocyte activation markers with noncalcified plaque in infected women. Grinspoon notes that while the association is plausible, since plaque formation includes accumulation of activated monocytes, it needs to be investigated further.

"We have found that these two factors – noncalcified plaque and immune activation – are uniquely and disproportionately increased among HIV-infected women and together may contribute to the markedly increased rates of HIV-infected women," he says. "These results suggest that strategies to reduce monocyte and immune activation may alter that elevated cardiovascular risk, particularly in older . It will be worthwhile to study whether adding therapies that reduce immune activation – including the statin drugs frequently prescribed to reduce cholesterol levels – to antiretroviral therapy can reduce this risk."

add to favorites email to friend print save as pdf

Related Stories

Increased anal cancer risk from HIV plus HPV dual infection

Dec 03, 2013

(Medical Xpress)—Human papillomavirus, or HPV, which can cause cervical cancer in women, is also known to cause anal cancer in both women and men. Now, a study led by researchers at the UCLA School of Nursing has found ...

Recommended for you

New study reveals why some people may be immune to HIV-1

Nov 20, 2014

Doctors have long been mystified as to why HIV-1 rapidly sickens some individuals, while in others the virus has difficulties gaining a foothold. Now, a study of genetic variation in HIV-1 and in the cells ...

Virus discovery could impact HIV drug research

Nov 20, 2014

A research team led by Portland State University (PSU) biology professor Ken Stedman has unlocked the structure of an unusual virus that lives in volcanic hot springs. The discovery could pave the way for better drugs to ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.